Literature DB >> 27886168

Hitting the right button: MAVS-mediated defense against HAV infection.

Percy A Knolle1.   

Abstract

Studying the immune response against infection with hepatitis viruses is hampered by the lack of suitable preclinical model systems. A recent publication in Science identifies the cytosolic adapter molecule MAVS as being responsible for species restriction of infection with hepatitis A virus as well as linking cytosolic immune sensing in infected hepatocytes with innate effector functions and protective adaptive immunity.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27886168      PMCID： PMC5223226          DOI： 10.1038/cr.2016.139

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  10 in total

1.  Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Authors:  Gregor Ebert; Simon Preston; Cody Allison; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Hamish W Scott; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; Ruth Chin; Danielle Colledge; Xin Li; Nadia Warner; Peter Revill; Scott Bowden; John Silke; C Glenn Begley; Marc Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

2.  MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; David R McGivern; Olga González-López; Anshuman Das; Hui Feng; Lu Sun; Justin E Wilson; Fengyu Hu; Zongdi Feng; William Lovell; Ichiro Misumi; Jenny P-Y Ting; Stephanie Montgomery; John Cullen; Jason K Whitmire; Stanley M Lemon
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

Review 3.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

4.  STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease.

Authors:  Jan Petrasek; Arvin Iracheta-Vellve; Timea Csak; Abhishek Satishchandran; Karen Kodys; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-19       Impact factor: 11.205

5.  Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

Authors:  Robert Besch; Hendrik Poeck; Tobias Hohenauer; Daniela Senft; Georg Häcker; Carola Berking; Veit Hornung; Stefan Endres; Thomas Ruzicka; Simon Rothenfusser; Gunther Hartmann
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.

Authors:  Nader Yatim; Hélène Jusforgues-Saklani; Susana Orozco; Oliver Schulz; Rosa Barreira da Silva; Caetano Reis e Sousa; Douglas R Green; Andrew Oberst; Matthew L Albert
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

Review 7.  In vivo models of hepatitis B and C virus infection.

Authors:  Benjamin Y Winer; Qiang Ding; Jenna M Gaska; Alexander Ploss
Journal:  FEBS Lett       Date:  2016-04-08       Impact factor: 4.124

8.  Ubiquitination of the Transcription Factor IRF-3 Activates RIPA, the Apoptotic Pathway that Protects Mice from Viral Pathogenesis.

Authors:  Saurabh Chattopadhyay; Teodora Kuzmanovic; Ying Zhang; Jaime L Wetzel; Ganes C Sen
Journal:  Immunity       Date:  2016-05-10       Impact factor: 31.745

9.  Completion of the entire hepatitis C virus life cycle in genetically humanized mice.

Authors:  Marcus Dorner; Joshua A Horwitz; Bridget M Donovan; Rachael N Labitt; William C Budell; Tamar Friling; Alexander Vogt; Maria Teresa Catanese; Takashi Satoh; Taro Kawai; Shizuo Akira; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

Review 10.  STING: infection, inflammation and cancer.

Authors:  Glen N Barber
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106
  10 in total
  2 in total

1.  Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

Authors:  Suhong Qian; Wenchun Fan; Tingting Liu; Mengge Wu; Huawei Zhang; Xiaofang Cui; Yun Zhou; Junjie Hu; Shaozhong Wei; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription.

Authors:  Xiaobin Zao; Jin Cheng; Congle Shen; Guiwen Guan; Xiaoyu Feng; Jun Zou; Jing Zhang; Tianxu Liu; Huiling Zheng; Ting Zhang; Jie Wang; Jia Liu; Deyao Li; Fengmin Lu; Fuping You; Xiangmei Chen
Journal:  Oncoimmunology       Date:  2021-01-11       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.